Most of the evidence concerns the SF-36 and EQ-5D , and for these instruments there was evidence for known group validity .
Although the evidence base is limited in a number of important respects , including problems with the measures used to develop constructs in the validation studies , it is sufficient to raise doubts about the use of generic measures of health like the EQ-5D and SF-36 in patients with schizophrenia
OBJECTIVES Generic health status measures such as the short form health survey ( SF-36 ) and EuroQol-5D ( EQ-5D ) are increasingly being used to inform health policy .
They are cl aim ed to be applicable across disease areas and have started to be used within mental health research .
This review aims to assess the construct validity and responsiveness of four generic health status measures in schizophrenia , including the preference-based SF-6D and EQ-5D .
Short-term symptomatic and functional outcomes of schizophrenia in Butajira, Ethiopia
BACKGROUND Prospect i ve outcome studies based on a community sample of mostly neuroleptic naive cases of schizophrenia are uncommon . OBJECTIVES To describe short-term symptomatic and functional outcomes of schizophrenia , and potential predictors of outcome . METHODS After a baseline assessment , 63 incident and 208 prevalent cases of schizophrenia were followed by a yearly clinical assessment for an average of 2.5 ( range 1 - 4 ) years . Scores of negative symptoms and positive symptoms were used as indicators of symptomatic outcomes . SF-36 scores of physical and social functioning , and role limitation due to mental health problems were used as indicators of functional outcomes . Several variables were evaluated as potential predictors of outcome in r and om coefficient models . RESULTS Functioning and other measures of health related quality of life were significantly diminished in cases as compared to the general population of the area at baseline and follow up . Of the socio-demographic and clinical factors evaluated , only lower negative and positive symptom scores were significantly associated with improvements in functioning . The level of functioning observed in cases from Butajira was lower than that reported for cases from developed countries . CONCLUSIONS Our findings are not in accord with other outcome studies that have reported better functional outcome for cases of schizophrenia from developing countries
Most of the evidence concerns the SF-36 and EQ-5D , and for these instruments there was evidence for known group validity .
Although the evidence base is limited in a number of important respects , including problems with the measures used to develop constructs in the validation studies , it is sufficient to raise doubts about the use of generic measures of health like the EQ-5D and SF-36 in patients with schizophrenia
OBJECTIVES Generic health status measures such as the short form health survey ( SF-36 ) and EuroQol-5D ( EQ-5D ) are increasingly being used to inform health policy .
They are cl aim ed to be applicable across disease areas and have started to be used within mental health research .
This review aims to assess the construct validity and responsiveness of four generic health status measures in schizophrenia , including the preference-based SF-6D and EQ-5D .